Organon (OGN) Stock Slides as Market Rises: Facts to Know Before You TradeZacks Investment Research • 10/06/25
Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 10/06/25
European Commission (EC) Approves Henlius and Organon's BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), RespectivelyBusiness Wire • 09/19/25
US Food and Drug Administration (FDA) Approves Henlius and Organon's BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), RespectivelyBusiness Wire • 09/02/25
NYSE: OGN Lawsuit Alert: Investors who lost money with Organon & Co. (NYSE: OGN) shares should contact the Shareholders FoundationPRNewsWire • 08/13/25
Organon (OGN) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 08/05/25
Insights Into Organon (OGN) Q2: Wall Street Projections for Key MetricsZacks Investment Research • 08/01/25
Organon (OGN) Sees a More Significant Dip Than Broader Market: Some Facts to KnowZacks Investment Research • 07/31/25
Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research • 07/29/25
Organon & Co. Investors: Please contact the Portnoy Law Firm to recover your losses. July 22, 2025 Deadline to file Lead Plaintiff MotionGlobeNewsWire • 07/22/25
Contact Levi & Korsinsky by July 22, 2025 Deadline to Join Class Action Against Organon & Co.(OGN)GlobeNewsWire • 07/22/25
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Organon & Co. of Class Action Lawsuit and Upcoming Deadlines - OGNPRNewsWire • 07/22/25
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of OrganonBusiness Wire • 07/22/25
Organon & Co. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 22, 2025 to Discuss Your Rights - OGNPRNewsWire • 07/22/25
ORGANON FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Organon & Co. (OGN) Investors of the July 22nd Deadline and Urges Them to Inquire About Their Rights in Class Action LawsuitGlobeNewsWire • 07/22/25